×
ADVERTISEMENT

MARCH 6, 2024

At-Risk Populations Appear to Be Embracing DoxyPEP


Originally published by our sister publication Infectious Disease Special Edition

By Marie Rosenthal, MS

Data presented at CROI 2024, in Denver, not only confirmed the efficacy of taking on-demand doxycycline after condomless sex (doxyPEP) as prophylaxis against bacterial sexually transmitted infections (STIs) but that many people for whom it is recommended have embraced it.

“This is an incredibly exciting topic,” said Landon Myer, MD, PhD, who moderated a CROI press briefing.